Health

Latest Health News

📅January 29, 2026 at 1:00 PM
Major health news includes US WHO withdrawal, Nipah outbreak in India, measles surges, cancer therapy advances, obesity projections, and drug overdose decline boosting life expectancy.
1

United States Officially Withdraws from WHO

The US pulled out of the World Health Organization on January 29, 2026, weakening global outbreak tracking and its own pandemic response capabilities.Source 3 Experts warn this makes the US more vulnerable to epidemics, losing access to crucial data and expertise while WHO loses its largest donor.Source 3 The US still owes WHO $260 million.Source 3

2

Nipah Virus Outbreak Confirmed in India

India reports a deadly Nipah virus outbreak in West Bengal with five cases, including healthcare workers, prompting quarantines of nearly 100 people.Source 3 Neighboring countries like Thailand, Nepal, and China are enhancing screening and alerts for travelers from India.Source 3 Nipah is highly lethal and transmissible.Source 3

3

Measles Cases Surge Across US States

States report first 2026 measles cases amid South Carolina outbreak nearing 800; Florida confirms three in Tampa Bay area patients aged 20-24.Source 1 A case was also confirmed in an Arizona ICE facility.Source 1 Health officials note some cases lack international travel history.Source 1

4

US Life Expectancy Hits Record High from Falling Overdoses

Drug overdoses dropped sharply, boosting US life expectancy to an all-time high, per Wall Street Journal report.Source 1 This marks a positive shift in substance abuse trends amid ongoing public health efforts.Source 1

5

Obesity Projected to Affect Nearly 50% of US Adults by 2035

A JAMA study forecasts 126 million American adults obese by 2035, based on CDC and Gallup data from over 11 million participants.Source 1 Current trends show rapid rise in medical obesity rates.Source 1

6

FDA Fast Tracks Multiple Cancer Therapies

BioNTech's BNT113 mRNA immunotherapy for HPV-positive head and neck cancer receives FDA Fast Track.Source 2 MAIA Biotechnology's ateganosine for lung cancer also got Fast Track with strong Phase 3 data.Source 2 Acrivon Therapeutics reports 39% response rate in ACR-368 cancer trial.Source 2

7

Pancreatic Cancer Research Gains Momentum with New Funding

US Defense bill allocates historic $20 million for pancreatic cancer research; phase 3 trials for targeted therapies set for 2026.Source 4 Advances include RAS inhibitors, PRMT5 targeting, and TTFields under FDA review.Source 4 Earlier detection and precision medicine offer optimism despite low survival rates.Source 4

8

Norway Tops Global Patient Safety Rankings, UK 21st

Imperial College report ranks Norway #1 in patient safety among 38 OECD countries; UK lags at 21st with 22,000 preventable deaths yearly.Source 5 UK sees rising excess mortality in mental illness and 103,000 treatment-related deaths in 2023.Source 5 Experts urge urgent NHS improvements.Source 5

9

New Stroke Guidelines Expand Endovascular Therapy

AHA/ASA updates recommend EVT for larger core strokes and add pediatric guidelines; promotes mobile stroke units.Source 1 Aims to improve early management outcomes.Source 1

10

Protein Buildup in Brain Vessels Raises Dementia Risk

Cerebral amyloid angiopathy weakens brain blood vessels, linked to 5-year increased dementia risk per American Heart Association.Source 7 Amyloid protein accumulation is key factor.Source 7

11

Tolebrutinib Advances for MS Disability Progression

Tolebrutinib, with prior FDA breakthrough designation, targets unmet need in MS disability progression.Source 9 New January 2026 research highlights potential.Source 9

Latest Health News | DeckBook AI